Nowa wersja platformy, zawierająca wyłącznie zasoby pełnotekstowe, jest już dostępna.
Przejdź na


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2013 | 8 | 5 | 591-596
Tytuł artykułu

Lithium and venlafaxine poisoning - a case report

Treść / Zawartość
Warianty tytułu
Języki publikacji
In treatment of manic-depressive conditions long-term lithium therapy may be combined with an effective and relatively safe antidepressant venlafaxine. Combined overdose may increase the risk of early toxicity of both drugs and of delayed lithium intoxication, responding to symptomatic and renal replacement therapy. We present a patient with combined lithium and venlafaxine self-poisoning with nothing but delayed signs of lithium intoxication with the emphasis on early and late treatment. 41-year old woman attempted suicide by large amount of lithium and venlafaxine. On admission she was asymptomatic, but with increased serum lithium over 5mmol/L. After gastric lavage, active charcoal and laxative administration she was receiving IV fluids. After a delay of 63 hours she deteriorated acutely by disorientation, confusion, fasciculation and tremor and was readmitted to Intensive care unit. In spite serum lithium decreased to 2mmol/L clinical signs were attributed to delayed lithium intoxication. After symptomatic and renal replacement therapy the patient’s condition improved after few days. We conclude that decontamination procedures are effective in particular for venlafaxine poisoning. If increased serum lithium levels are noted renal replacement therapy may be started even in asymptomatic patients as delayed lithium intoxication is most likely after few days.
Słowa kluczowe

Opis fizyczny
  • Department of medical intensive care, University clinical centre Maribor, Ljubljanska 5, SI-2000, Maribor, Slovenia
  • Department of medical intensive care, University clinical centre Maribor, Ljubljanska 5, SI-2000, Maribor, Slovenia
  • Department of medical intensive care, University clinical centre Maribor, Ljubljanska 5, SI-2000, Maribor, Slovenia
  • [1] Timmer R.T., Sands J.M., Lithium intoxication, J. Am. Soc. Nephrol., 1999, 10, 666–674
  • [2] Grandjean E.M., Aubry J.M., Lithium: Update human knowledge using an evidence-based approach, C.N.S. Drugs, 2009, 23, 397–418[Crossref]
  • [3] Chen K.P., Shen W.W., Lu M.L., Implication of serum concentration monitoring in patients with lithium intoxication, Psychiatry. Clin. Neurosci., 2004, 58, 25–29[Crossref]
  • [4] Malhi G.S., Tanious M., Optimal frequency of lithium administration in the treatment of bipolar disorder: clinical and dosing considerations, C.N.S. Drugs, 2011, 25, 289–298[WoS][Crossref]
  • [5] Chiu C.C., Shen W.W., Chen K.P., Lu M.L., Application of the Cockcroft-Gault method to estimate lithium dosage requirement, Psychiatry. Clin. Neurosci., 2007, 61, 269–274[WoS][Crossref]
  • [6] Yoshimura R., Yamada Y., Ueda N., Nakamura J., Changes in plasma monoamine metabolites during acute lithium intoxication, Hum. Psychopharmacol., 2000, 15, 357–360<357::AID-HUP174>3.0.CO;2-K[Crossref]
  • [7] Dupuis R.E., Cooper A.A., Rosamond L.J., Campbell-Bright S., Multiple delayed peak lithium concentrations following acute intoxication with an extended-release product, Ann. Pharmacother., 1996, 30, 356–360
  • [8] Müller-Oerlinghausen B., Drug interactions with lithium: a guide for clinicians, C.N.S. Drugs, 1999, 11, 41–48[Crossref]
  • [9] Birmes P., Coppin D., Schmitt L., Lauque D., Serotonine syndrome: a brief review, C.M.A.J., 2003, 168, 1439–1442
  • [10] Adan-Manes J., Novalbos J., Lopez-Rodriguez R., Ayuso-Mateos J.L., Abad-Santos F., Lithium and venlafaxine interactions: a case of serotonin syndrome, J. Clin. Pharm. Therapeutics, 2006, 31, 397–400[Crossref]
  • [11] Harrison C.L., Ferrier N., Young A.H., Tolerability of high-dose venlafaxine in depressed patients, J. Psychopharmacol., 2004, 18, 200–2004[Crossref]
  • [12] Fisher M., Unterecker S., Pfuhlmann B., Overdose of venlafaxine with mild outcome, Neuroscience & Medicine, 2012, 3, 327–329[Crossref]
  • [13] Kumar V.V.P., Isbister G.K., Dufful S., The effect of decontamination procedures on the pharmacodynamics of venlafaxine in overdose, Br. J. Clin. Pharmacol., 2011, 72, 125–132[Crossref]
  • [14] Isbister G.K., Electrocardiogram changes and arrhythmias in venlafaxine overdose, Br. J. Clin. Pharmacol., 2009, 67,5, 572–576[Crossref]
  • [15] Okusa M.D., Crystal L.J., Clinical manifestations and management of acute lithium intoxication, Am. J. Med., 1994, 97, 383–389[Crossref]
  • [16] Bosinski T., Bailie G.R., Eisele G., Massive and extended rebound of serum lithium concentrations following hemodialysis in two chronic overdose cases, Am. J. Emerg. Med., 1998, 16, 98–100[Crossref]
  • [17] Bosse G.M., Spiller M.S., Collins A.M., A fatal case of venlafaxine overdose, J. Med. Toxicol., 2008, 4, 18–20[Crossref]
  • [18] Nordt P.S., Cantrell F., L., Elevated lithium level: a case and brief overview of lithium poisoning, Psycosom. Med., 1999, 61, 564–565 [Crossref]
  • [19] Vermeire S., Vanbrabant P., Van Boxstael P., Sabbe M., Severity (and treatment) of chronic lithium poisoning: clinical signs or lab results as a criterion?, Acta. Clin. Belg., 2010, 65, 127–128 [WoS][PubMed][Crossref]
  • [20] Puhr J., Hack J., Early J., Price W., Meggs W., Lithium overdose with electrocardiogram changes suggesting ischemia, J. Med. Toxicol., 2008, 4, 170–172[Crossref]
  • [21] Goodman J.W., Goldfarb D.S., The role of continuous renal replacement therapy in the treatment of poisoning, Semin. Dial., 2006, 19, 402–407[Crossref]
Typ dokumentu
Identyfikator YADDA
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.